TRAIL upregulated in tumor cells after Ad/IL-24 infection. »
06/06/23

Knockdown of GYS1 impaired proliferation of breast cancer cells. »
06/06/23

CXCR4 drives trastuzumab resistance in HER2+ breast cancer. »
06/06/23

Black participants reported more frequently that they were offered written assessment and care plan. »
01/06/23

Favorable OS rates following re-RT and identified prognostic factors. »
04/02/23

Validated nine-gene-based classifier to predict patients’ stemness subtype. »
06/08/23

Surgery continued to be associated with improved survival. »
06/08/23

Higher myeloid diversity robustly associated with more favorable clinical outcomes. »
06/07/23

Nomogram stratified patients into two subgroups with distinct prognosis. »
06/07/23

Burden of cancer-associated VTE substantial. »
06/10/23